OnKure Therapeutics (OKUR) Treasury Shares (2020 - 2026)

OnKure Therapeutics (OKUR) has 7 years of Treasury Shares data on file, last reported at $32642.0 in Q1 2026.

• Quarterly Treasury Shares fell 76.18% year-over-year to $32642.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32642.0 (down 76.18% YoY) and the FY2025 annual result came in at $41376.0, down 80.6% from the prior year.
• Treasury Shares eased to $32642.0 in Q1 2026, from $41376.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $441500.0 in Q3 2023 to a low of $29659.0 in Q3 2024.
• A 5-year average of $222431.1 and a median of $279500.0 in 2022 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares tumbled 99.4% — and 2025, when it soared 73.35%.
• Tracing OKUR's Treasury Shares over 5 years: stood at $329500.0 in 2022, then plunged by 34.92% to $214436.0 in 2023, then slipped by 0.55% to $213254.0 in 2024, then tumbled by 80.6% to $41376.0 in 2025, then decreased by 21.11% to $32642.0 in 2026.
• The last three Treasury Shares figures came in at $32642.0 (Q1 2026), $41376.0 (Q4 2025), and $51415.0 (Q3 2025), per Business Quant data.